Literature DB >> 20171523

Radiation dose-volume effects in the esophagus.

Maria Werner-Wasik1, Ellen Yorke, Joseph Deasy, Jiho Nam, Lawrence B Marks.   

Abstract

Publications relating esophageal radiation toxicity to clinical variables and to quantitative dose and dose-volume measures derived from three-dimensional conformal radiotherapy for non-small-cell lung cancer are reviewed. A variety of clinical and dosimetric parameters have been associated with acute and late toxicity. Suggestions for future studies are presented. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20171523      PMCID： PMC3587781          DOI： 10.1016/j.ijrobp.2009.05.070

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  35 in total

1.  Fitting of normal tissue tolerance data to an analytic function.

Authors:  C Burman; G J Kutcher; B Emami; M Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

2.  Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors.

Authors:  Issam El Naqa; Jeffrey Bradley; Angel I Blanco; Patricia E Lindsay; Milos Vicic; Andrew Hope; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-15       Impact factor: 7.038

3.  Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration.

Authors:  Edith M T Dieleman; Suresh Senan; Andrew Vincent; Frank J Lagerwaard; Ben J Slotman; John R van Sörnsen de Koste
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-01       Impact factor: 7.038

4.  Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.

Authors:  Hiroshi Onishi; Hiroki Shirato; Yasushi Nagata; Masahiro Hiraoka; Masaharu Fujino; Kotaro Gomi; Yuzuru Niibe; Katsuyuki Karasawa; Kazushige Hayakawa; Yoshihiro Takai; Tomoki Kimura; Atsuya Takeda; Atsushi Ouchi; Masato Hareyama; Masaki Kokubo; Ryusuke Hara; Jun Itami; Kazunari Yamada; Tsutomu Araki
Journal:  J Thorac Oncol       Date:  2007-07       Impact factor: 15.609

5.  Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.

Authors:  Núria Rodríguez; Manuel Algara; Palmira Foro; Marti Lacruz; Anna Reig; Ismael Membrive; Joan Lozano; José Luis López; Jaime Quera; Enric Fernández-Velilla; Xavier Sanz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-26       Impact factor: 7.038

6.  Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.

Authors:  Steven E Schild; William L McGinnis; David Graham; Shauna Hillman; Tom R Fitch; Donald Northfelt; Yolanda I Garces; Homayoon Shahidi; Loren K Tschetter; Paul L Schaefer; Alex Adjei; James Jett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-26       Impact factor: 7.038

7.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Authors:  Robert Timmerman; Ronald McGarry; Constantin Yiannoutsos; Lech Papiez; Kathy Tudor; Jill DeLuca; Marvene Ewing; Ramzi Abdulrahman; Colleen DesRosiers; Mark Williams; James Fletcher
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

8.  Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer.

Authors:  A William Blackstock; Coty Ho; Jerome Butler; June Fletcher-Steede; L Douglas Case; William Hinson; Antonius A Miller
Journal:  J Thorac Oncol       Date:  2006-06       Impact factor: 15.609

9.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.

Authors:  K Furuse; M Fukuoka; M Kawahara; H Nishikawa; Y Takada; S Kudoh; N Katagami; Y Ariyoshi
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

10.  Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer.

Authors:  Thomas E Stinchcombe; Carrie B Lee; Dominic T Moore; M Patricia Rivera; Jan Halle; Steven Limentani; Julian G Rosenman; Mark A Socinski
Journal:  J Thorac Oncol       Date:  2008-11       Impact factor: 15.609
View more
  72 in total

1.  Effect of modified Zhuye Shigao Decoction and its components on preventing radiation esophagitis of rats.

Authors:  Jun-zhang Lu; Chen Wang; Ming-hui Yang; Hong Zhao; Yi Liu; Xiu-tang Cao
Journal:  Chin J Integr Med       Date:  2014-06-21       Impact factor: 1.978

2.  Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors.

Authors:  Abraham J Wu; Eric Williams; Ankit Modh; Amanda Foster; Ellen Yorke; Andreas Rimner; Andrew Jackson
Journal:  Radiother Oncol       Date:  2014-07-23       Impact factor: 6.280

3.  Palliative radiotherapy for thoracic spine metastases: Dosimetric advantage of three-dimensional conformal plans.

Authors:  Seung-Gu Yeo
Journal:  Oncol Lett       Date:  2015-05-13       Impact factor: 2.967

4.  An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.

Authors:  Marie Wanet; Antoine Delor; François-Xavier Hanin; Benoît Ghaye; Aline Van Maanen; Vincent Remouchamps; Christian Clermont; Samuel Goossens; John Aldo Lee; Guillaume Janssens; Anne Bol; Xavier Geets
Journal:  Strahlenther Onkol       Date:  2017-07-21       Impact factor: 3.621

5.  PET/CT-guided treatment planning for paediatric cancer patients: a simulation study of proton and conventional photon therapy.

Authors:  J S Kornerup; N P Brodin; T Björk-Eriksson; C Birk Christensen; A Kiil-Berthelsen; M C Aznar; C Hollensen; E Markova; P Munck Af Rosenschöld
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

Review 6.  [Rare inflammatory diseases of the esophagus].

Authors:  Florian Hentschel; Stefan Lüth
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

Review 7.  Predicting outcomes in radiation oncology--multifactorial decision support systems.

Authors:  Philippe Lambin; Ruud G P M van Stiphout; Maud H W Starmans; Emmanuel Rios-Velazquez; Georgi Nalbantov; Hugo J W L Aerts; Erik Roelofs; Wouter van Elmpt; Paul C Boutros; Pierluigi Granone; Vincenzo Valentini; Adrian C Begg; Dirk De Ruysscher; Andre Dekker
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

8.  Feasibility of normal tissue dose reduction in radiotherapy using low strength magnetic field.

Authors:  Nuri Hyun Jung; Youngseob Shin; In-Hye Jung; Jungwon Kwak
Journal:  Radiat Oncol J       Date:  2015-09-30

9.  Cohort-based T-SSIM Visual Computing for Radiation Therapy Prediction and Exploration.

Authors:  A Wentzel; P Hanula; T Luciani; B Elgohari; H Elhalawani; G Canahuate; D Vock; C D Fuller; G E Marai
Journal:  IEEE Trans Vis Comput Graph       Date:  2019-08-22       Impact factor: 4.579

10.  Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy.

Authors:  Marta Scorsetti; Piera Navarria; Fiorenza De Rose; AnnaMaria Ascolese; Elena Clerici; Ciro Franzese; Francesca Lobefalo; Giacomo Reggiori; Pietro Mancosu; Stefano Tomatis; Antonella Fogliata; Luca Cozzi
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-17       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.